OC
LLY icon

Oakworth Capital’s Eli Lilly LLY Stock Holding History

Oakworth Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.61M Sell
4,682
-7
-0.1% -$7.15K 0.27% 35
2026
Q1 		$4.31M Buy
4,689
+632
+16% +$641K 0.23% 37
2025
Q4 		$4.36M Buy
4,057
+30
+0.7% +$28.7K 0.24% 35
2025
Q3 		$3.07M Buy
4,027
+92
+2% +$68.5K 0.18% 44
2025
Q2 		$3.07M Buy
3,935
+23
+0.6% +$17.9K 0.2% 37
2025
Q1 		$3.23M Buy
3,912
+20
+0.5% +$16.6K 0.23% 35
2024
Q4 		$3M Buy
3,892
+8
+0.2% +$6.62K 0.21% 36
2024
Q3 		$3.44M Buy
3,884
+79
+2% +$71K 0.24% 34
2024
Q2 		$3.44M Buy
3,805
+381
+11% +$305K 0.25% 35
2024
Q1 		$2.66M Sell
3,424
-209
-6% -$149K 0.2% 43
2023
Q4 		$2.12M Buy
3,633
+181
+5% +$106K 0.17% 42
2023
Q3 		$1.85M Buy
3,452
+30
+0.9% +$15.5K 0.17% 44
2023
Q2 		$1.6M Sell
3,422
-549
-14% -$230K 0.14% 49
2023
Q1 		$1.36M Hold
3,971
– – 0.12% 52
2022
Q4 		$1.45M Hold
3,971
– – 0.14% 45
2022
Q3 		$1.28M Buy
3,971
+22
+0.6% +$6.97K 0.14% 49
2022
Q2 		$1.28M Hold
3,949
– – 0.13% 52
2022
Q1 		$1.13M Sell
3,949
-105
-3% -$27K 0.1% 67
2021
Q4 		$1.12M Buy
4,054
+207
+5% +$52.5K 0.1% 65
2021
Q3 		$888K Sell
3,847
-250
-6% -$61.7K 0.09% 69
2021
Q2 		$940K Buy
4,097
+252
+7% +$50.6K 0.09% 67
2021
Q1 		$718K Sell
3,845
-32
-0.8% -$6.26K 0.08% 78
2020
Q4 		$654K Sell
3,877
-18
-0.5% -$2.69K 0.08% 79
2020
Q3 		$577K Sell
3,895
-18
-0.5% -$2.79K 0.09% 75
2020
Q2 		$643K Buy
3,913
+50
+1% +$7.67K 0.12% 71
2020
Q1 		$535K Hold
3,863
– – 0.13% 68
2019
Q4 		$517K Hold
3,863
– – 0.09% 83
2019
Q3 		$432K Sell
3,863
-2,379
-38% -$265K 0.08% 90
2019
Q2 		$692K Sell
6,242
-93
-1% -$11K 0.13% 70
2019
Q1 		$822K Sell
6,335
-78
-1% -$9.48K 0.17% 56
2018
Q4 		$742K Sell
6,413
-651
-9% -$72.7K 0.17% 57
2018
Q3 		$758K Buy
7,064
+11
+0.2% +$1.1K 0.15% 64
2018
Q2 		$602K Buy
7,053
+706
+11% +$58K 0.12% 70
2018
Q1 		$514K Sell
6,347
-911
-13% -$73.3K 0.12% 78
2017
Q4 		$614K Buy
7,258
+544
+8% +$46.3K 0.14% 70
2017
Q3 		$546K Hold
6,714
– – 0.14% 77
2017
Q2 		$552K Buy
6,714
+20
+0.3% +$1.63K 0.15% 71
2017
Q1 		$563K Buy
6,694
+1,019
+18% +$81.6K 0.16% 69
2016
Q4 		$380K Buy
5,675
+990
+21% +$73.7K 0.12% 93
2016
Q3 		$376K Sell
4,685
-358
-7% -$28.7K 0.13% 89
2016
Q2 		$379K Buy
5,043
+234
+5% +$17.6K 0.14% 84
2016
Q1 		$346K Buy
4,809
+95
+2% +$7.19K 0.14% 87
2015
Q4 		$398K Buy
4,714
+3,710
+370% +$308K 0.17% 77
2015
Q3 		$84K Hold
1,004
– – 0.04% 119
2015
Q2 		$85K Hold
1,004
– – 0.04% 126
2015
Q1 		$72K Hold
1,004
– – 0.03% 163
2014
Q4 		$69K Hold
1,004
– – 0.04% 159
2014
Q3 		$64K Hold
1,004
– – 0.04% 121
2014
Q2 		$62K Sell
1,004
-50
-5% -$2.98K 0.04% 124
2014
Q1 		$62K Hold
1,054
– – 0.04% 122
2013
Q4 		$54K Buy
+1,054
New +$52.8K 0.04% 117

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Oakworth Capital's LLY Position: Q2 2026 in Review

Oakworth Capital reduced its Eli Lilly (LLY) stake by 0.15% in Q2 2026, selling an estimated $7.15K and leaving 4,682 shares worth $5.61M. The position accounts for 0.27% of the portfolio, ranked #35.

Oakworth Capital first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oakworth Capital held 4,682 shares of Eli Lilly worth $5.61M as of Q2 2026.
  • Oakworth Capital sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.27% of Oakworth Capital's portfolio in Q2 2026, its #35 holding.
  • Oakworth Capital first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.